Outlook Therapeutics Inc (STU:41O)
€ 0.55 +0.0025 (+0.46%) Market Cap: 134.88 Mil Enterprise Value: 141.05 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 23/100

Q3 2026 Outlook Therapeutics Inc Earnings Call Transcript

Aug 14, 2026 / 12:30PM GMT
Release Date Price: €0.6495 (-15.54%)
Operator

Hello, everyone, and welcome to the Outlook Therapeutics Third Quarter Fiscal Year 2026 Corporate Update Conference Call and Webcast. As a brief reminder, all participants are currently in a listen-only mode. If anyone requires operator assistance during the event, please press *0 on your telephone keypad.

( Operators Instructions )

As a result, you should not place undue reliance on any forward-looking statements, some of the factors that could cause active results differ materially from those contemplated by such forward-looking statements and discussed in the periodic reports Outlook Therapeutics Files and Securities and Exchange Commissions. These documents are available in the investor sections of the company's website and on the Securities Exchange Commission's website. We encourage you to review these documents. Carefully. Additionally, certain information contained in the website relates to or is based on studies, publications, surveys, and other data obtained from third-party sources and the company's own estimates and research, while the adequacy, fairness, and accuracy of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot